McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help ...

Netflix scores a hit with Christmas Day NFL games, how Medicare plans, working with PBMs, fueled opioid sales, and more news ...

Wellpath, a health care provider for hospitals, prisons and jails, has been dogged by wrongful death and medical negligence ...

As the U.S. opioid crisis deepened, Medicare plans administered by UnitedHealth and CVS Health were a top source of OxyContin ...

McKinsey said in a statement on Friday that it's “deeply sorry” for its work for Purdue Pharma. “We should have appreciated the harm opioids were causing in our society and we should not ...

Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times ...

McKinsey & Co. will pay $650 million in penalties to the U.S. Department of Justice (DOJ) to settle charges that it advised ...

Novo Holdings can proceed with its planned $16.5 billion acquisition of Catalent after U.S. regulators declined to challenge ...

McKinsey & Co has agreed to pay $650 million to resolve charges over advice it provided Purdue Pharma on how to “turbocharge” sales of its addictive painkiller OxyContin, the U.S. Department of ...

BOSTON — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the ...